AUSTIN RAWLINS: Open Payments
NPI 1265132286 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$925 in 46 payments from 18 companies in 2025. Trend: 2023 $468 · 2024 $984 · 2025 $925
Food & beverage: $925
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $117 |
| Lundbeck LLC | 4 | $97 |
| Paratek Pharmaceuticals, Inc. | 4 | $85 |
| Eisai Inc. | 3 | $84 |
| ABBVIE INC. | 5 | $75 |
| Novo Nordisk Inc | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Exact Sciences Corporation | 2 | $41 |
Products named: REXULTI, NUZYRA, Leqembi, CAPLYTA, VRAYLAR, TRELEGY ELLIPTA, Cologuard Collection Kit, WATCHMAN Access System.
Industry payments across GA — which companies pay providers there.
